Bongiovanni, A., Foca, F., Menis, J., Menis, J., Menis, J., Stucci, S. L., . . . Ibrahim, T. (2021). Immune Checkpoint Inhibitors With or Without Bone-Targeted Therapy in NSCLC Patients With Bone Metastases and Prognostic Significance of Neutrophil-to-Lymphocyte Ratio. Frontiers Media S.A.
Style de citation Chicago (17e éd.)Bongiovanni, Alberto, et al. Immune Checkpoint Inhibitors With or Without Bone-Targeted Therapy in NSCLC Patients With Bone Metastases and Prognostic Significance of Neutrophil-to-Lymphocyte Ratio. Frontiers Media S.A, 2021.
Style de citation MLA (8e éd.)Bongiovanni, Alberto, et al. Immune Checkpoint Inhibitors With or Without Bone-Targeted Therapy in NSCLC Patients With Bone Metastases and Prognostic Significance of Neutrophil-to-Lymphocyte Ratio. Frontiers Media S.A, 2021.